PTC Therapeutics, Inc. PTCT closed lower on Thursday following the company’s decision to withdraw its New Drug Application ...
In a statement, PTC's chief executive, Matthew Klein, said the company had decided to pull the filing for Translarna (ataluren) as a treatment for nonsense mutation DMD after the FDA said it was ...
Barchart on MSN
PTC stock outlook: Is Wall Street bullish or bearish?
Boston, Massachusetts-based PTC Inc. (PTC) provides software solutions and services globally that aid manufacturing companies in designing, operating, and managing products. With a market cap. of $18.
Investing.com -- PTC Inc (NASDAQ:PTC) stock fell 3.8% on Thursday after Google announced a major upgrade to its Gemini 3 Deep Think AI system, potentially challenging PTC’s position in the engineering ...
Product design software company PTC (NASDAQ:PTC) will be reporting earnings this Wednesday after the bell. Here’s what ...
Product design software company PTC (NASDAQ:PTC) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with ...
PTC Inc. (PTC) delivered earnings and revenue surprises of +20.47% and +7.43%, respectively, for the quarter ended December ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results